These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17161727)

  • 21. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximizing the benefits of screening mammography for women 40-49 years old.
    Bastardis-Zakas K; Iatrakis G; Navrozoglou I; Peitsidis P; Salakos N; Malakassis P; Zervoudis S
    Clin Exp Obstet Gynecol; 2010; 37(4):278-82. PubMed ID: 21355457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer screening with mammography: overview of Swedish randomised trials.
    Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
    Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.
    Jacklyn G; Glasziou P; Macaskill P; Barratt A
    Br J Cancer; 2016 May; 114(11):1269-76. PubMed ID: 27124337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
    Berrington de González A; Reeves G
    Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
    Mittra I; Mishra GA; Dikshit RP; Gupta S; Kulkarni VY; Shaikh HKA; Shastri SS; Hawaldar R; Gupta S; Pramesh CS; Badwe RA
    BMJ; 2021 Feb; 372():n256. PubMed ID: 33627312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
    Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years.
    Moss S; Thomas I; Evans A; Thomas B; Johns L;
    Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Irwig L; McGeechan K; Jacklyn G; Thornton H; Dhillon H; Houssami N; McCaffery K
    Lancet; 2015 Apr; 385(9978):1642-52. PubMed ID: 25701273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
    Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
    BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updated results of the Gothenburg Trial of Mammographic Screening.
    Bjurstam NG; Björneld LM; Duffy SW
    Cancer; 2016 Jun; 122(12):1832-5. PubMed ID: 27061821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.